Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PI3K/mTOR Inhibitor-1 is a potent, orally bioavailable dual inhibitor of PI3K/mTOR (PI3Kα/PI3Kβ/PI3Kδ/PI3Kγ/mTOR with IC50s of 20/376/204/46/186 nM)
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約8-10 週間 | ¥ 486,500 |
50 mg | 約8-10 週間 | ¥ 638,000 |
100 mg | 約8-10 週間 | ¥ 849,500 |
説明 | PI3K/mTOR Inhibitor-1 is a potent, orally bioavailable dual inhibitor of PI3K/mTOR (PI3Kα/PI3Kβ/PI3Kδ/PI3Kγ/mTOR with IC50s of 20/376/204/46/186 nM) |
ターゲット&IC50 | mTOR:186 nM, PI3Kγ:204 nM, PI3Kα:20 nM, PI3Kβ:376 nM, PI3Kδ:46 nM |
In vitro | PI3K/mTOR Inhibitor-1 (Compound 26) as a potent dual PI3K/mTOR inhibitor.?It exhibited high inhibitory activity against PI3Kα/β/γ/δ (IC50 = 20/376/204/46 nM) and mTOR (IC50 = 189 nM), potent functional suppression of AKT phosphorylation (IC50 = 196 nM), and excellent antiproliferative effects on a panel of cancer cells.?Enzymic data and modeling simulation indicate that a cyclopropyl ring on the C4 sulfone chain and a fluorine on the C6 aminopyridyl moiety are responsible for its maintained PI3K activity and enhanced mTOR potency, respectively. |
In vivo | PI3K/mTOR Inhibitor-1 (Compound 26) exhibited higher efficiency(antiproliferative effects) in the HT-29 colorectal carcinoma xenograft model at the daily dose of 3.75 and 7.5 mg/kg relative to BKM120 at the dose of 15 and 30 mg/kg. |
分子量 | 407.46 |
分子式 | C18H22FN5O3S |
CAS No. | 1949802-49-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PI3K/mTOR Inhibitor-1 1949802-49-6 PI3K/Akt/mTOR signaling PI3K PI3K/mTOR Inhibitor1 PI-3K/mTOR Inhibitor-1 PI3K/mTOR Inhibitor 1 Inhibitor inhibitor inhibit